Skip to main content

Table 1 Summary of patient demographic and disease characteristics

From: ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients

Variable

Total

ADAM8 H-SCORE category

P-value

Population

High

Low

Negative

Nā€‰=ā€‰490

Nā€‰=ā€‰115

Nā€‰=ā€‰51

Nā€‰=ā€‰324

H-score

0.0 (0.0, 300.0)

200.0 (200.0, 300.0)

100.0 (50.0, 150.0)

0.0 (0.0, 0.0)

<ā€‰0.0001

Age at diagnosis

59.5 (28.5, 94.8)

67.3 (31.0, 94.8)

58.3 (34.5, 83.7)

58.0 (28.5, 93.2)

<ā€‰0.0001

HER2 status

0.1069

Ā Negative

393 (80.2%)

86 (74.8%)

46 (90.2%)

261 (80.6%)

Ā 

Ā Positive

57 (11.6%)

14 (12.2%)

3 (5.9%)

40 (12.3%)

Ā 

Ā Unknown

40 (8.2%)

15 (13.0%)

2 (3.9%)

23 (7.1%)

Ā 

ER status

0.7491

Ā Negative

107 (22.0%)

28 (24.3%)

12 (23.5%)

67 (20.9%)

Ā 

Ā Positive

362 (74.3%)

81 (70.4%)

37 (72.5%)

244 (76.0%)

Ā 

Ā Unknown

18 (3.7%)

6 (5.2%)

2 (3.9%)

10 (3.1%)

Ā 

PR status

0.2145

Ā Negative

160 (32.7%)

44 (38.3%)

13 (25.5%)

103 (31.9%)

Ā 

Ā Positive

293 (59.9%)

65 (56.5%)

31 (60.8%)

197 (61.0%)

Ā 

Ā Unknown

36 (7.4%)

6 (5.2%)

7 (13.7%)

23 (7.1%)

Ā 

Race

0.9142

Ā Asian

2 (0.4%)

Ā Ā 

2 (0.6%)

Ā 

Ā Black/African American

108 (22.0%)

29 (25.2%)

11 (21.6%)

68 (21.0%)

Ā 

Ā Other

1 (0.2%)

Ā Ā 

1 (0.3%)

Ā 

Ā Unknown

2 (0.4%)

1 (0.9%)

Ā 

1 (0.3%)

Ā 

Ā White

377 (76.9%)

85 (73.9%)

40 (78.4%)

252 (77.8%)

Ā 

Ethnicity

0.0007

Ā Hispanic or Latino

4 (0.8%)

1 (0.9%)

1 (2.0%)

2 (0.6%)

Ā 

Ā Non-Hispanic

364 (74.3%)

100 (87.0%)

42 (82.4%)

222 (68.5%)

Ā 

Ā Unknown

122 (24.9%)

14 (12.2%)

8 (15.7%)

100 (30.9%)

Ā 
  1. Baseline demographic and disease characteristics for the 490 patients whose samples were analyzed for ADAM8 expression are summarized as median (range) for continuous variables, and number and percentage for categorical variables. Following staining and scoring of the TMA samples with the ADP2-based IHC assay, comparisons between the Negative, Low and High ADAM8 expression groups, defined as patients having tumors with ADAM8 H-scores of 0, 50ā€“150 and 200ā€“300, respectively, were done using Chi-square test (or Fisherā€™s Exact test, where appropriate) for categorical variables, or Wilcoxon test for continuous variables. Analysis was conducted using SAS 9.4 software. P-values are as indicated. Nā€‰=ā€‰number of patients